Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHeadlam Regulatory News (HEAD)

Share Price Information for Headlam (HEAD)

Share Price is delayed by 15 minutes
Get Live Data
28.40    -1.00 (-3.40%)
Bid:
28.10
Ask:
28.30
Spread: 0.20 (0.712%)
Market Cap: £22.80m
HEAD Live PriceLast checked at - London Stock Exchange

Intraday Headlam Share Chart

Performance Share Plan awards

9 Apr 2021 14:28

RNS Number : 0253V
Headlam Group PLC
09 April 2021
 

9 April 2021

Headlam Group plc

(the 'Company')

 

Grant of awards under the Company's Performance Share Plan ('PSP')

On 9 April 2021, the Company granted awards in the form of nil-cost options over a total of 265,360 ordinary shares in the Company under the Company's PSP (the '2021 PSP'), including 151,180 to the following Executive Directors and Persons Discharging Managerial Responsibility ('PDMR'):

Executive Director/ PDMR

Position

Number of ordinary shares over which options granted

Steve Wilson

Chief Executive

87,043

Chris Payne

Chief Financial Officer

64,137

As detailed on pages 101 and 102 of the 2020 Annual Report and Accounts, the PSP awards vest dependent on the achievement of relative Total Shareholder Return and absolute Earnings Per Share performance conditions measured over a three-year performance period. In addition, the awards are further subject to an underpin performance condition that the extent of vesting reflects the overall financial performance of the Company over the three-year performance period. When making this determination the Company's Remuneration Committee will have full discretion to ensure that the final outcome is warranted based on the performance of the Company in the light of all relevant factors to ensure there have been no windfall gains.

PSP awards granted to Executive Directors are additionally subject to a two-year holding period following the date of vesting during which a dividend equivalent will accrue in the form of additional shares to the extent the awards vest, as calculated on a re-investment basis.

The number of ordinary shares over which the awards were granted was based on a share price of 454.2 pence per ordinary share, being the average mid-market closing share price for the five business days prior to the grant date, as derived from the London Stock Exchange daily official list.

The awards, which are subject to the Malus and Clawback conditions of the PSP, will ordinarily vest on the latest of three years following the date of grant or the date on which the Company's Remuneration Committee determines the extent to which the performance conditions have been satisfied.

 

 

 Enquiries:

 

Headlam Group plc

Steve Wilson, Chief Executive

Chris Payne, Chief Financial Officer

Catherine Miles, Director of Communications

Tel: 01675 433 000

Email: headlamgroup@headlam.com

Investec Bank plc (Corporate Broker)

David Flin / Alex Wright

Tel: 020 7597 5970

 

 

Panmure Gordon (UK) Limited (Corporate Broker)

Erik Anderson / Dominic Morley / Ailsa MacMaster

Tel: 020 7886 2500

 

Alma PR (Financial PR)

Susie Hudson / Harriet Jackson / Faye Calow

 

Tel: 020 3405 0205

headlam@almapr.co.uk

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Steve Wilson

2.

Reason for the notification

a)

Position / status

Chief Executive

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer

a)

Name

Headlam Group plc

 

b)

LEI

213800I4AZZUJEYX9O90

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

b)

Identification code

ISIN: GB0004170089

c)

Nature of the transaction

Grant of nil-cost options over ordinary shares under the Company's Performance Share Plan

d)

Price(s) and

volume(s)

Price(s)

Volume(s)

N/A

87,043

 

e)

Aggregated information

- Volume

- Price

N/A

f)

Date of the transaction

9 April 2021

g)

Place of the transaction

Outside a trading venue

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Chris Payne

2.

Reason for the notification

 

 

a)

Position / status

Chief Financial Officer

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer

a)

Name

Headlam Group plc

 

b)

LEI

213800I4AZZUJEYX9O90

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

b)

Identification code

ISIN: GB0004170089

c)

Nature of the transaction

Grant of nil-cost options over ordinary shares under the Company's Performance Share Plan

d)

Price(s) and

volume(s)

Price(s)

Volume(s)

N/A

64,137

 

e)

Aggregated information

- Volume

- Price

N/A

f)

Date of the transaction

9 April 2021

g)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBXGDSUDGDGBC
Date   Source Headline
8th Nov 20211:26 pmRNSDirector/PDMR Shareholding
2nd Nov 202111:13 amRNSDirector/PDMR Shareholding
1st Nov 20212:29 pmRNSTotal Voting Rights
28th Oct 20211:32 pmRNSOption Exercise and Transfer of Treasury Shares
13th Oct 20214:08 pmRNSOption Exercise and Transfer of Treasury Shares
7th Oct 20217:00 amRNSDirectorate Change
30th Sep 20211:31 pmRNSTotal Voting Rights
29th Sep 20211:39 pmRNSOption Exercise and Transfer of Treasury Shares
24th Sep 20211:04 pmRNSDirector/PDMR Shareholding
15th Sep 20212:33 pmRNSOption Exercise and Transfer of Treasury Shares
2nd Sep 20214:02 pmRNSOption Exercise and Transfer of Treasury Shares
2nd Sep 20217:00 amRNSInterim Results
31st Aug 202111:11 amRNSTotal Voting Rights
18th Aug 20211:48 pmRNSOption Exercise and Transfer of Treasury Shares
4th Aug 20212:47 pmRNSOption Exercise and Transfer of Treasury Shares
2nd Aug 20211:07 pmRNSTotal Voting Rights
29th Jul 20217:00 amRNSPre-Close Trading Update
14th Jul 20211:18 pmRNSOption Exercise and Transfer of Treasury Shares
7th Jul 20211:53 pmRNSOption Exercise and Transfer of Treasury Shares
2nd Jul 20213:37 pmRNSOption Exercise and Transfer of Treasury Shares
1st Jul 20217:00 amRNSCapital Markets Day and Trading Update
30th Jun 202112:57 pmRNSTotal Voting Rights
23rd Jun 20219:45 amRNSOption Exercise and Transfer of Treasury Shares
22nd Jun 20217:00 amRNSAppointment of Non-Executive Director
9th Jun 20211:39 pmRNSOption Exercise and Transfer of Treasury Shares
1st Jun 202110:47 amRNSTotal Voting Rights
21st May 202112:51 pmRNSResult of AGM
21st May 20217:01 amRNSPublication of ESG Strategy Report
21st May 20217:00 amRNSAGM Trading Update
14th May 20217:00 amRNSAppointment of Non-Executive Director
12th May 20211:01 pmRNSOption Exercise and Transfer of Treasury Shares
30th Apr 20217:00 amRNSDisposal of Swiss Business
9th Apr 20212:28 pmRNSPerformance Share Plan awards
31st Mar 20214:50 pmRNSExercise of share options and TVR
24th Mar 202111:59 amRNSAnnual Report and Accounts and Notice of AGM
10th Mar 202111:56 amRNSDividend Payment Date
9th Mar 20217:00 amRNSFinal Results
1st Mar 20213:58 pmRNSTotal Voting Rights
2nd Feb 20213:36 pmRNSOption Exercise and Transfer of Treasury Shares.
1st Feb 20219:48 amRNSTotal Voting Rights
21st Jan 202112:19 pmRNSHolding(s) in Company
21st Jan 20217:00 amRNSTrading Update
6th Jan 202110:47 amRNSOption Exercise and Transfer of Treasury Shares
6th Jan 20217:00 amRNSCOVID-19 Operational Update
31st Dec 202011:31 amRNSTotal Voting Rights
22nd Dec 202011:31 amRNSOption Exercise and Transfer of Treasury Shares
16th Dec 20207:00 amRNSDirectorate Change
8th Dec 20209:41 amRNSOption Exercise and Transfer of Treasury Shares
4th Dec 202011:00 amRNSAdditional Listing and Total Voting Rights
1st Dec 20208:17 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.